Loading practices
Loading practices
Every practice in the library, in one list. Narrow it by how long you have, who it is written for, and where you are right now.
A medicine can help some people and still fail to win approval for a condition. Modafinil is the usual example, cleared for a sleep disorder and short of the bar for attention.
Approval turns on trials showing a clear enough average effect for that specific use, and an average can be respectable within a subgroup while…
Being given a medicine that holds no licence for your condition can feel like being experimented on. Usually it means the evidence is decent but thinner than a licence demands.
Bupropion is the common case. It helps some people with attention difficulties, often alongside a stimulant, and it never gained the indication, so…
You may hear that being treated as a child leaves an advantage that lasts even after you stop. It is a comforting claim and the strongest evidence does not quite bear it out.
The best known childhood trial followed its participants into their twenties. The early advantage of the assigned treatment faded, and the group…
Stimulants are not the only licensed route. Atomoxetine, guanfacine and clonidine all hold approval for attention difficulties, and they matter when a stimulant cannot be used.
They usually sit after stimulants rather than beside them, because the comparative evidence still favours stimulants overall. They come into their…
Looking for a whole subject rather than a single practice? Start from the nine areas.